Multiple Sclerosis

Search for publications

Only original articles, editorials, guidelines.

  • Sádaba MC, Tzartos J, Paíno C, García-Villanueva M, Alvarez-Cermeño JC, Villar LM, Esiri MM.

    Axonal and oligodendrocyte-localized IgM and IgG deposits in MS lesions

    JOURNAL OF NEUROIMMUNOLOGY . 247(1-2): 86-94. Number of citations: 30

    [doi:10.1016/j.jneuroim.2012.03.020]

  • Fernández Ó, Álvarez-Cermeño JC, Arroyo-González R, Brieva L, Calles-Hernández MC, Casanova-Estruch B, Comabella M, de las Heras V, García-Merino JA, Hernández-Pérez MA, Izquierdo G, Meca-Lallana JE, Muñoz-García D, Olascoaga J, Oreja-Guevara C, Prieto JM, Ramió-Torrentà L, Rodríguez-Antigüedad A, Romero-Pinel L, Sanchez F, Téllez N, Tintoré M, Montalban X.

    Review of the novelties presented at the 27th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (I)

    REVISTA DE NEUROLOGIA . 54(11): 677-691. Number of citations: 13

    [doi:10.33588/rn.5411.2012204]

  • Martínez-Viñambres E, García-Trujillo JA, Rodríguez-Martín E, Villar LM, Coll J, Roldán E.

    CD29 expressed on plasma cells is activated by divalent cations and soluble CD106 contained in the bone marrow plasma: refractory activation is associated with enhanced proliferation and exit of clonal plasma cells to circulation in multiple myeloma patients

    Leukemia . 26(5): 1098-1105. Number of citations: 5

    [doi:10.1038/leu.2011.335]

  • Meca-Lallana JE, Balseiro JJ, Lacruz F, Guijarro C, Sanchez O, Cano A, Costa-Frossard L, Hernández-Clares R, Sanchez-de la Rosa R.

    Spasticity improvement in patients with relapsing-remitting multiple sclerosis switching from interferon-beta to glatiramer acetate: The Escala Study

    JOURNAL OF THE NEUROLOGICAL SCIENCES . 315(1-2): 123-128. Number of citations: 7

    [doi:10.1016/j.jns.2011.11.010]

  • de la Concha EG, Cavanillas ML, Cénit MC, Urcelay E, Arroyo R, Fernández Ó, Álvarez-Cermeño JC, Leyva L, Villar LM, Núñez C.

    DRB1*03:01 Haplotypes: Differential Contribution to Multiple Sclerosis Risk and Specific Association with the Presence of Intrathecal IgM Bands

    Plos One . 7(2): . Number of citations: 9

    [doi:10.1371/journal.pone.0031018]

  • Villar LM, García-Sánchez MI, Costa-Frossard L, Espiño M, Roldán E, Páramo D, Lucas M, Izquierdo G, Álvarez-Cermeño JC.

    Immunological Markers of Optimal Response to Natalizumab in Multiple Sclerosis

    ARCHIVES OF NEUROLOGY . 69(2): 191-197. Number of citations: 41

    [doi:10.1001/archneurol.2011.971]

  • Magraner MJ, Bosca I, Simó-Castelló M, García-Martí G, Alberich-Bayarri A, Coret F, Alvarez-Cermeño JC, Martí-Bonmatí L, Villar LM, Casanova B.

    Brain atrophy and lesion load are related to CSF lipid-specific IgM oligoclonal bands in clinically isolated syndromes

    Neuroradiology . 54(1): 5-12. Number of citations: 43

    [doi:10.1007/s00234-011-0841-7]

  • del Campo R, Martínez E, del Fresno C, Alenda R, Gómez-Piña V, Fernández-Ruíz I, Siliceo M, Jurado T, Toledano V, Arnalich F, García-Río F, López-Collazo E.

    Translocated LPS might cause endotoxin tolerance in circulating monocytes of cystic fibrosis patients.

    Plos One . 6(12): . Number of citations: 29

    [doi:10.1371/journal.pone.0029577]

  • Santón A, Cristóbal E, Aparicio M, Royuela A, Villar LM, Alvarez-Cermeño JC.

    High frequency of co-infection by Epstein-Barr virus types 1 and 2 in patients with multiple sclerosis

    MULTIPLE SCLEROSIS JOURNAL . 17(11): 1295-1300. Number of citations: 22

    [doi:10.1177/1352458511411063]

  • Abraira V, Alvarez-Cermeño JC, Arroyo R, Cámara C, Casanova B, Cubillo S, de Andrés C, Espejo C, Fernández O, Ferrer J, Figueredo MA, García-Merino A, García-Sánchez MI, García-Trujillo JA, Gómez M, González-Oria C, Gosis A, Izquierdo G, Jímenez J, López-Trascasa M, Montalbán X, Moreno MJ, Muñoz D, Nuñez V, Muriel A, Navarro J, Olascoaga J, Oreja-Guevara C, Prada A, Ramil E, Ramo-Tello C, Rodríguez C, Rodríguez E, Rodríguez-Frías F, Rodríguez-Antigüedad A, Rodríguez-Molina JJ, Ruiz E, Saiz A, Sarasola E, Simó M, Yagüe J, Villar LM.

    Utility of oligoclonal IgG band detection for MS diagnosis in daily clinical practice

    JOURNAL OF IMMUNOLOGICAL METHODS . 371(1-2): 170-173. Number of citations: 20

    [doi:10.1016/j.jim.2011.06.009]

  • Villar LM, Espiño M, Roldán E, Marín N, Costa-Frossard L, Muriel A, Alvarez-Cermeño JC.

    Increased peripheral blood CD5+B cells predict earlier conversion to MS in high-risk clinically isolated syndromes

    MULTIPLE SCLEROSIS JOURNAL . 17(6): 690-694. Number of citations: 22

    [doi:10.1177/1352458510396922]

  • Villar LM, Espiño M, Cavanillas ML, Roldán E, Urcelay E, de la Concha EG, Sádaba MC, Arroyo R, González-Porqué P, Alvarez-Cermeño JC.

    Immunological mechanisms that associate with oligoclonal IgM band synthesis in multiple sclerosis

    CLINICAL IMMUNOLOGY . 137(1): 51-59. Number of citations: 26

    [doi:10.1016/j.clim.2010.06.007]

  • Boscá I, Magraner MJ, Coret F, Alvarez-Cermeño JC, Simó-Castelló M, Villar LM, Casanova B.

    The risk of relapse after a clinically isolated syndrome is related to the pattern of oligoclonal bands

    JOURNAL OF NEUROIMMUNOLOGY . 226(1-2): 143-146. Number of citations: 30

    [doi:10.1016/j.jneuroim.2010.05.032]

  • Bosca I, Villar LM, Coret F, Magraner MJ, Simó-Castelló M, Alvarez-Cermeño JC, Casanova B.

    Response to interferon in multiple sclerosis is related to lipid-specific oligoclonal IgM bands

    MULTIPLE SCLEROSIS JOURNAL . 16(7): 810-815. Number of citations: 19

    [doi:10.1177/1352458510371961]

  • Comabella M, Fernández M, Martin R, Rivera-Vallvé S, Borrás E, Chiva C, Julià E, Rovira A, Cantó E, Alvarez-Cermeño JC, Villar LM, Tintoré M, Montalban X.

    Cerebrospinal fluid chitinase 3-like 1 levels are associated with conversion to multiple sclerosis

    Brain . 133(4): 1082-1093. Number of citations: 188

    [doi:10.1093/brain/awq035]

  • Bridel C, van Wieringen WN, Zetterberg H, Tijms BM, Teunissen CE, and the NFL Group, Alvarez-Cermeño JC, Andreasson U, Axelsson M, Bäckström DC, Bartos A, Bjerke M, Blennow K, Boxer A, Brundin L, Burman J, Christensen T, Fialová L, Forsgren L, Frederiksen JL, Gisslén M, Gray E, Gunnarsson M, Hall S, Hansson O, Herbert MK, Jakobsson J, Jessen-Krut J, Janelidze S, Johannsson G, Jonsson M, Kappos L, Khademi M, Khalil M, Kuhle J, Landén M, Leinonen V, Logroscino G, Lu CH, Lycke J, Magdalinou NK, Malaspina A, Mattsson N, Meeter LH, Mehta SR, Modvig S, Olsson T, Paterson RW, Pérez-Santiago J, Piehl F, Pijnenburg YAL, Pyykkö OT, Ragnarsson O, Rojas JC, Romme Christensen J, Sandberg L, Scherling CS, Schott JM, Sellebjerg FT, Simone IL, Skillbäck T, Stilund M, Sundström P, Svenningsson A, Tortelli R, Tortorella C, Trentini A, Troiano M, Turner MR, van Swieten JC, Vågberg M, Verbeek MM, Villar LM, Visser PJ, Wallin A, Weiss A, Wikkelsø C, Wild EJ.

    Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis.

    JAMA NEUROLOGY . : .

    [doi:10.1001/jamaneurol.2019.1534]

  • Pérez-Torre P, López-Sendón JL, Mañanes Barral V, Parees I, Fanjul-Arbós S, Monreal E, Alonso-Canovas A, Martínez Castrillo JC.

    Concomitant treatment with safinamide and antidepressant drugs: Safety data from real clinical practice.

    NEUROLOGIA . : .

    [doi:10.1016/j.nrl.2021.08.004]

  • Cuello JP, Martínez Ginés ML, García Domínguez JM, Tejeda-Velarde A, Lozano Ros A, Higueras Y, Meldaña Rivera A, Goicochea Briceño H, Garcia-Tizon S, de León-Luis J, Medina Heras S, Fernández Velasco JI, Pérez-Pérez S, García-Martínez MÁ, Pardo-Rodríguez B, Domínguez-Mozo MI, García-Calvo E, Estévez H, Luque-García JL, Villar LM, Alvarez-Lafuente R.

    Short-chain fatty acids during pregnancy in multiple sclerosis: A prospective cohort study.

    EUROPEAN JOURNAL OF NEUROLOGY . : .

    [doi:10.1111/ene.15150]